Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception.
Publication
, Journal Article
Garman, KS
Published in: Cell Mol Gastroenterol Hepatol
2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cell Mol Gastroenterol Hepatol
DOI
EISSN
2352-345X
Publication Date
2021
Volume
12
Issue
2
Start / End Page
787 / 788
Location
United States
Related Subject Headings
- Humans
- Esophageal Neoplasms
- Adenocarcinoma
- 3202 Clinical sciences
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Garman, K. S. (2021). Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception. Cell Mol Gastroenterol Hepatol, 12(2), 787–788. https://doi.org/10.1016/j.jcmgh.2021.04.018
Garman, Katherine S. “Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception.” Cell Mol Gastroenterol Hepatol 12, no. 2 (2021): 787–88. https://doi.org/10.1016/j.jcmgh.2021.04.018.
Garman KS. Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception. Cell Mol Gastroenterol Hepatol. 2021;12(2):787–8.
Garman, Katherine S. “Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception.” Cell Mol Gastroenterol Hepatol, vol. 12, no. 2, 2021, pp. 787–88. Pubmed, doi:10.1016/j.jcmgh.2021.04.018.
Garman KS. Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception. Cell Mol Gastroenterol Hepatol. 2021;12(2):787–788.
Published In
Cell Mol Gastroenterol Hepatol
DOI
EISSN
2352-345X
Publication Date
2021
Volume
12
Issue
2
Start / End Page
787 / 788
Location
United States
Related Subject Headings
- Humans
- Esophageal Neoplasms
- Adenocarcinoma
- 3202 Clinical sciences
- 3101 Biochemistry and cell biology